Fig. 4From: High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome a Plots and curves showing no association between CAIX and any response b survival curve showing significant relationship with increasing CAIX expressionBack to article page